Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery (LETSVN)
Use of Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery, With or Without Adenoids
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Región Metropolitana
-
Santiago, Región Metropolitana, Chile, 8330024
- División de Anestesia - Facultad de Medicina Pontificia Universidad Católica
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children between 2 and 12 years
- ASA I or II
- Programmed for elective tonsillectomy with or without adenoidectomy under general anesthesia
Exclusion Criteria:
- Obesity, defined as body mass index (BMI) ≥ 95th percentile for age and sex.
- Use of antiemetic drugs during the 24 hours before surgery.
- Gastroesophageal reflux.
- History of allergy to any of the drugs used in the study.
- Down Syndrome.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Group L
Group L Lidocaine load dose 1.5 mg / kg over 5 minutes, followed by continuous infusion of 2 mg / kg / h, which is maintained until the end of surgical procedure
|
Bolus 1.5 mg/kg over 5 minutes, then an infusion of 2 mg/kg/h
|
|
Placebo Comparator: Group P
Normal saline solution administered under the same regimen
|
Sodium Chloride 0.9% infusion
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluating the effectiveness of intravenous lidocaine during anesthesia to decrease the numbers of events (vomiting) during the immediate postoperative period up to 24 hours postoperatively, comparing to placebo
Time Frame: 24 hours
|
24 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The prevention of the composite "nausea / or vomiting"
Time Frame: 24 hours
|
24 hours
|
|
Compare frequency of vomiting by baseline risk
Time Frame: 24 hours
|
24 hours
|
|
Time to first vomiting
Time Frame: 24 hours
|
24 hours
|
|
Time at which discharge criteria are met Postanesthesia care unit (PACU)
Time Frame: 24 hours
|
24 hours
|
|
Length of stay in PACU unit
Time Frame: 24 hours
|
24 hours
|
|
PACU opioid consumption
Time Frame: 24 hours
|
24 hours
|
|
Postoperative pain using Children and Infants Postoperative Pain Scale , face or Visual analogue Scale, as appropriate
Time Frame: 24 hours
|
24 hours
|
|
Postoperative agitation using Pediatric Anesthesia Emergence Delirium Scale
Time Frame: 24 hours
|
24 hours
|
|
Time to first emetic drug administered
Time Frame: 24 hours
|
24 hours
|
|
Type and number of doses of antiemetic drug required during hospitalization
Time Frame: 24 hours
|
24 hours
|
|
Total length of stay
Time Frame: 24 hours
|
24 hours
|
|
Analysis of cost-effectiveness.
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Fernando R Altermatt, MD, Pontificia Universidad Católica de Chile
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Signs and Symptoms, Digestive
- Nausea
- Vomiting
- Postoperative Nausea and Vomiting
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
Other Study ID Numbers
- PG 08-12
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.